Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sander de Kort
Observed names:
S de Kort,
S. De Kort,
S. de Kort
Institution:
St. Anna Ziekenhuis
Observed institutions:
Maastricht University Medical Centre,
Maastricht University,
VieCuri Medisch Centrum,
St. Anna Ziekenhuis,
Care and Public Health Research Institute
ORCID:
0000-0001-6956-0821
Observed ORCID:
0000-0001-6956-0821
OpenAlex ID:
A5085530822
Leaky gut and diabetes mellitus: what is the link?
2011
·
S. de Kort
, D. Keszthelyi
, et al.
·
Obesity Reviews
·
235
Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case–control study
2010
·
D. Keszthelyi
, S. V. Jansen
, et al.
·
Alimentary Pharmacology & Therapeutics
·
147
PDF
Higher risk of colorectal cancer in patients with newly diagnosed diabetes mellitus before the age of colorectal cancer screening initiation
2017
·
Sander de Kort
, Ad A. M. Masclee
, et al.
·
Scientific Reports
·
75
PDF
Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer
2016
·
Sander de Kort
, C.C.J.M. Simons
, et al.
·
European Journal of Gastroenterology & Hepatology
·
44
Gastrointestinal symptoms in diabetes mellitus, and their relation to anxiety and depression
2012
·
Sander de Kort
, Joanna W. Kruimel
, et al.
·
Diabetes Research and Clinical Practice
·
42
No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure
2017
·
Roy G. de Jong
, Andrea M. Burden
, et al.
·
Cancer Prevention Research
·
36
PDF
Diabetes mellitus, genetic variants in the insulin‐like growth factor pathway and colorectal cancer risk
2019
·
Sander de Kort
, Colinda C.J.M. Simons
, et al.
·
International Journal of Cancer
·
33
PDF
Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus
2017
·
R.G.P.J. de Jong
, A.M. Burden
, et al.
·
European Journal of Cancer
·
20
PDF
Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study
2024
·
Rozanne C. de Veer
, Maria C.B. van Hooff
, et al.
·
JHEP Reports
·
16
Incidence of Cancer in Patients With Familial Adenomatous Polyposis in the Netherlands: A Nationwide Cohort Study
2026
·
Hicham Bouchiba
, Arthur S. Aelvoet
, et al.
·
Gastroenterology
·
11
Significantly higher rates of multiple and proximally located adenomas among patients with diabetes mellitus: A cross‐sectional population‐based study
2016
·
Sander de Kort
, Mariëlle WE Bouwens
, et al.
·
United European Gastroenterology Journal
·
5
PDF
Pancreatic cancer risk and survival in patients with Lynch syndrome: a nationwide Dutch cohort study
2026
·
Aleksander M. Bogdanski
, Derk C.F. Klatte
, et al.
·
EClinicalMedicine
·
4
TOP-348-YI The association between metabolic comorbidities and clinical outcome in patients with primary biliary cholangitis
2025
·
Ellen Werner
, Gemma Weijsters
, et al.
·
Journal of Hepatology
·
1
Su1038 Increased Prevalence of Proximal and Multiple Adenomas in Patients With Diabetes Mellitus
2013
·
Sander de Kort
, Mariëlle Bouwens
, et al.
·
Gastroenterology
·
1
Extrahepatic Autoimmune Disease in People With Primary Biliary Cholangitis: Nationwide Occurrence and Relation to Outcome
2026
·
Gemma H.X. Weijsters
, Ellen Werner
, et al.
·
Clinical Gastroenterology and Hepatology
PDF
Bezafibrate for primary biliary cholangitis: A number needed to treat analysis
2026
·
Ellen Werner
, Maria A. van de Vrie
, et al.
·
JHEP Reports
PDF
THU-120-YI The impact of ursodeoxycholic acid on biochemistry of patients with primary biliary cholangitis in a nationwide cohort
2024
·
Ellen Werner
, Maria C. van Hooff
, et al.
·
Journal of Hepatology
Supplementary Table 2 from No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure
2023
·
Roy G. de Jong
, Andrea M. Burden
, et al.
Supplementary Table 1 from No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure
2023
·
Roy G. de Jong
, Andrea M. Burden
, et al.
Supplementary Table 1 from No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure
2023
·
Roy G. de Jong
, Andrea M. Burden
, et al.
Supplementary Table 2 from No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure
2023
·
Roy G. de Jong
, Andrea M. Burden
, et al.
Data from No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure
2023
·
Roy G. de Jong
, Andrea M. Burden
, et al.
Data from No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure
2023
·
Roy G. de Jong
, Andrea M. Burden
, et al.
A rare cause of haematuria.
2014
·
S de Kort
, A C W Borstlap
, et al.
·
PubMed
Het voorkomen van gastro-intestinale symptomen bij patiënten met diabetes mellitus en de relatie met angst en depressie
2012
·
S. de Kort
, J.W. Kruimel
, et al.
·
Nederlands Tijdschrift voor Diabetologie
Show more works
View as search
Works count:
26
Citation count:
670
H-index:
10
I10-index:
10
Year
Topic
Type